Health Condition 1: J22- Unspecified acute lower respiratory infection
Conditions
Interventions
Intervention1: NIL: NIL
Intervention2: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Society For Applied Studies
Eligibility
Inclusion criteria
Inclusion criteria: 1.Live birth 2.Available for enrolment within 14 days of birth 3.Family planning to stay in the study area until 2 years after childbirth 4.Parental consent for participation of their child Tier 2 1.Under-five children hospitalized for following respiratory infection symptoms, cough, shortness of breath with RR more than 60 for infant below 2 months, more than 50 for infants 2-12 months and more than 40 for children above 1 year, onset within the past 10 days 2.Contact at 90 days after discharge is feasible 3.Additional criteria for infants 0-6 months age, Apnoea, Sepsis, fever (more than equal to 37.5°C) or hypothermia (less than 35.5°C), shock (lethargy, fast breathing, cold skin, prolonged capillary refill, or fast weak pulse), seriously ill with no apparent cause 4.Parental consent for participation of their child
Exclusion criteria
Exclusion criteria: 1.Twins or triplets 2.Documented birth weight under 1500 grams or weight under 1500 grams at enrolment 3.Gestational age less than 32 weeks 4.HIV positive or born to women with known HIV infection For Tier 2: 1.Presenting complaints/diagnosis for hospitalization are non-respiratory 2.Respiratory infection is healthcare associated i.e. presenting complaints of cough or shortness of breath began 48 hours after admission. 3.Diagnosed case of HIV or primary immunodeficiency 4.Children receiving chemotherapy or immunomodulator therapy 5.Children with major congenital anomalies affecting the cardiovascular, neural and respiratory system 6. Others - as per investigator evaluation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the burden (incidence) of ARI and ALRI and the relative contribution of the viral causes (cumulative and individually) in ALRITimepoint: 24 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine predictors of severe disease, case fatality & disease outcomes, long-term sequelae among children with ARI & ALRITimepoint: 24 months;To study awareness & practices, treatment seeking behaviours & antibiotic use related to ARI & ALRI using mix of qualitative & quantitative methodsTimepoint: 24 months;To understand mono vs co-infections, spectrum of illness & seasonal & spatial trends.Timepoint: 24 months | — |
Countries
India
Contacts
Public ContactDr Temsunaro Rongsen Chandola
Society for Applied Studies
Outcome results
None listed